Becoming a global leader in biosimilars development

Becoming a global leader in biosimilars development
Home Leadership
Leadership Team
Our Promoters
P.V. Ram Prasad Reddy
Non-Executive Director
K. Nityananda Reddy
Vice Chairman & Managing Director
Our Senior Leadership
Dr. Satakarni Makkapati
Chief Executive Officer
Dr. Disha Dadke
Head – R&D, Regulatory, and Clinical Sciences
Dr. Venkata Ramireddy Yeturu
Head – Program Management and Business Development
Dr. Raghu Chitta
Head – Product Development
Dr. Tarun Sharma
Head – Vaccines Development
Dr. Arpitkumar Prajapati
Head – Clinical Sciences
Mr. Jaspreet Singh
Head – Quality
Latest News

Press Release
31 January 25
CuraTeQ Biologics receives CHMP positive opinion for Pegfilgrastim biosimilar
Read More
Press Release
21 December 24
CuraTeQ Biologics receives UK MHRA approval for Bevqolva™ (Bevacizumab biosimilar)
Read More
Press Release
13 December 24
CuraTeQ Biologics receives CHMP positive opinion for Filgrastim biosimilar
Read More
Press Release
12 November 24
EMA grants GMP certificate to CuraTeQ Biologics’ manufacturing facility in Hyderabad
Read More
Press Release
15 March 24
CuraTeQ Biologics successfully completes Phase 1 trial for Omalizumab biosimilar
Read More
Press Release
17 February 24
Auro Peptides completes US FDA inspection with zero observations
Read More
Press Release
17 January 24
CuraTeQ Biologics’ Trastuzumab Biosimilar receives recommendation for marketing authorization in India
Read More
Press Release
20 November 23
CuraTeQ Biologics eyes ‘WuXi’ moment to kickstart Indian bio-CDMO sector
Read More
Press Release
10 July 23